Synthesis, characterization, computational study, DNA binding and molecular docking studies of chromium (III) drug-based complexes

Synthesis, crystal structural description, DNA binding, molecular docking, and anticancer evaluation of the novel platinum(IV) supramolecular complex

A novel platinum(IV) supramolecular complex; [PtCl2(2,2'-bipy)2](PtCl6) was synthesized in aqueous acetonitrile solution at ambient temperature with constant stirring. The structure was confirmed by elemental analysis, FT-IR, UV-vis, NMR spectroscopy, and single-crystal X-ray diffraction, revealing a unique distorted octahedral geometry and a three-dimensional network stabilized by hydrogen bonding and π-π stacking. DNA binding studies, including electronic absorption titration and viscometry, indicated a groove binding mechanism with a binding constant (Kb) of 5.00 × 10⁶ M-1. Molecular docking with DNA (PDB ID: 1BNA) and cancer-related proteins (PDB codes: 3ig7, 3eqm, 4fm9) supports these interactions, while in vitro anticancer assays demonstrated potent cytotoxicity with IC₅₀ values of 41.37 μM for HepG2, 47.62 μM for HCT116, and 73.90 μM for MDA-MB-231 cells, outperforming cisplatin in selectivity. This study not only advances our understanding of structure-activity relationships in platinum-based complexes but also highlights the potential of this complex as a promising candidate for developing more effective and less toxic anticancer agents.

Resurgence and Repurposing of Antifungal Azoles by Transition Metal Coordination for Drug Discovery

Coordination compounds featuring one or more antifungal azole (AA) ligands constitute an interesting family of candidate molecules, given their medicinal polyvalence and the viability of drug complexation as a strategy to improve and repurpose available medications. This review reports the work performed in the field of coordination derivatives of AAs synthesized for medical purposes by discussing the corresponding publications and emphasizing the most promising compounds discovered so far. The resulting overview highlights the efficiency of AAs and their metallic species, as well as the potential still lying in this research area.

Theoretical Investigation by DFT and Molecular Docking of Synthesized Oxidovanadium(IV)-Based Imidazole Drug Complexes as Promising Anticancer Agents

Vanadium compounds have been set in various fields as anticancer, anti-diabetic, anti-parasitic, anti-viral, and anti-bacterial agents. This study reports the synthesis and structural characterization of oxidovanadium(IV)-based imidazole drug complexes by the elemental analyzer, molar conductance, magnetic moment, spectroscopic techniques, as well as thermal analysis. The obtained geometries were studied theoretically using density functional theory (DFT) under the B3LYP level. The DNA-binding nature of the ligands and their synthesized complexes has been studied by the electronic absorption titrations method. The biological studies were carried with in-vivo assays and the molecular docking method. The EPR spectra asserted the geometry around the vanadium center to be a square pyramid for metal complexes. The geometries have been confirmed using DFT under the B3LYP level. Moreover, the quantum parameters proposed promising bioactivity of the oxidovanadium(IV) complexes. The results of the DNA-binding revealed that the investigated complexes bind to DNA via non-covalent mode, and the intrinsic binding constant (K_b) value for the [VO(SO₄)(MNZ)₂] H₂O complex was promising, which was 2.0 × 10⁶ M⁻¹. Additionally, the cytotoxic activity of the synthesized complexes exhibited good inhibition toward both hepatocellular carcinoma (HepG-2) and human breast cancer (HCF-7) cell lines. The results of molecular docking displayed good correlations with experimental cytotoxicity findings. Therefore, these findings suggest that our synthesized complexes can be introduced as effective anticancer agents.

Exploring the charge transfer dynamics of hydrogen bonded crystals of 2-methyl-8-quinolinol and chloranilic acid: synthesis, spectrophotometric, single-crystal, DFT/PCM analysis, antimicrobial, and DNA binding studies

The new chemistry of the hydrogen-bonded charge and proton transfer complex (HB CT) between electron-donor 2-methyl-8-quinolinol (2 MQ) and electron-acceptor chloranilic acid (CHLA) has been studied using electronic absorption spectroscopy in acetonitrile (ACN), methanol (MeOH), and ethanol (EtOH) polar media at room temperature. The stoichiometric proportion of the HB CT complex was observed to be 1 : 1 from the Job data and photometric titration process. The association constant (K CT) and molar absorptivity (ε CT) of the HB CT complex were determined by using the modified Benesi-Hildebrand equation in three polarities. Other spectroscopic physical parameters like the energy of interaction (E CT), ionization potential (I D), resonance energy (R N), standard free energy change (ΔG°), oscillator strength (f), and transition dipole moment (μ) were also evaluated. The HB CT complex structure was confirmed by different characterization techniques, such as FT-IR, NMR, TGA-DTA, and SEM-EDX analysis. Powder XRD and single-crystal XRD were used to determine the nature and structure of the synthesized HB CT complex. DNA binding studies for the HB CT complex produced a good binding constant value of 2.25 × 104 L mol-1 in UV-visible and 1.17 × 104 L mol-1 in fluorescence spectroscopy. The biological activity of the HB CT complex was also tested in vitro against the growth of bacteria and fungi, and the results indicated remarkable activity for the HB CT complex compared to the standard drugs, ampicillin and clindamycin. Hence, the abovementioned biological results of the synthesized HB CT complex show it could be used as a pharmaceutical drug in the future. Computational analysis was carried out by DFT studies using the B3LYP function with a basis set of 6-31G(d,p) in the gas phase and PCM analysis. The computational studies further supported the experimental results by confirming the charge and proton transfer complex.